ORASURE TECHNOLOGIES INC (OSUR) Stock Fundamental Analysis

NASDAQ:OSUR • US68554V1089

2.825 USD
-0.02 (-0.88%)
Last: Feb 19, 2026, 12:51 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Taking everything into account, OSUR scores 2 out of 10 in our fundamental rating. OSUR was compared to 185 industry peers in the Health Care Equipment & Supplies industry. The financial health of OSUR is average, but there are quite some concerns on its profitability. OSUR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • OSUR had negative earnings in the past year.
  • OSUR had a negative operating cash flow in the past year.
  • OSUR had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: OSUR reported negative operating cash flow in multiple years.
OSUR Yearly Net Income VS EBIT VS OCF VS FCFOSUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

  • With a Return On Assets value of -14.24%, OSUR perfoms like the industry average, outperforming 57.30% of the companies in the same industry.
  • OSUR has a better Return On Equity (-16.64%) than 62.16% of its industry peers.
Industry RankSector Rank
ROA -14.24%
ROE -16.64%
ROIC N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
OSUR Yearly ROA, ROE, ROICOSUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • OSUR has a worse Gross Margin (40.41%) than 67.03% of its industry peers.
  • OSUR's Gross Margin has declined in the last couple of years.
  • OSUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
OSUR Yearly Profit, Operating, Gross MarginsOSUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • OSUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for OSUR has been increased compared to 1 year ago.
  • OSUR has more shares outstanding than it did 5 years ago.
  • OSUR has a better debt/assets ratio than last year.
OSUR Yearly Shares OutstandingOSUR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OSUR Yearly Total Debt VS Total AssetsOSUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • OSUR has an Altman-Z score of 1.98. This is not the best score and indicates that OSUR is in the grey zone with still only limited risk for bankruptcy at the moment.
  • OSUR has a better Altman-Z score (1.98) than 63.24% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that OSUR is not too dependend on debt financing.
  • OSUR has a better Debt to Equity ratio (0.00) than 75.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.98
ROIC/WACCN/A
WACC9.98%
OSUR Yearly LT Debt VS Equity VS FCFOSUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

  • OSUR has a Current Ratio of 7.03. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
  • OSUR has a better Current ratio (7.03) than 85.95% of its industry peers.
  • OSUR has a Quick Ratio of 6.20. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
  • OSUR has a Quick ratio of 6.20. This is amongst the best in the industry. OSUR outperforms 87.57% of its industry peers.
Industry RankSector Rank
Current Ratio 7.03
Quick Ratio 6.2
OSUR Yearly Current Assets VS Current LiabilitesOSUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • OSUR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -633.33%.
  • The Revenue for OSUR has decreased by -43.95% in the past year. This is quite bad
  • OSUR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.75% yearly.
EPS 1Y (TTM)-633.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
Revenue 1Y (TTM)-43.95%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-32.14%

3.2 Future

  • OSUR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.37% yearly.
  • The Revenue is expected to decrease by -4.62% on average over the next years.
EPS Next Y-239.35%
EPS Next 2Y-72.67%
EPS Next 3Y-41.36%
EPS Next 5Y25.37%
Revenue Next Year-38.37%
Revenue Next 2Y-20.05%
Revenue Next 3Y-11.49%
Revenue Next 5Y-4.62%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
OSUR Yearly Revenue VS EstimatesOSUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
OSUR Yearly EPS VS EstimatesOSUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for OSUR. In the last year negative earnings were reported.
  • Also next year OSUR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OSUR Price Earnings VS Forward Price EarningsOSUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OSUR Per share dataOSUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

  • A cheap valuation may be justified as OSUR's earnings are expected to decrease with -41.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-72.67%
EPS Next 3Y-41.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • OSUR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ORASURE TECHNOLOGIES INC

NASDAQ:OSUR (2/19/2026, 12:51:37 PM)

2.825

-0.02 (-0.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05
Earnings (Next)02-25
Inst Owners90.28%
Inst Owner Change-2.89%
Ins Owners5.58%
Ins Owner Change0.29%
Market Cap202.64M
Revenue(TTM)125.70M
Net Income(TTM)-60.24M
Analysts80
Price Target4.59 (62.48%)
Short Float %5.77%
Short Ratio6.46
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.19%
Min EPS beat(2)-24.34%
Max EPS beat(2)1.96%
EPS beat(4)1
Avg EPS beat(4)-41.25%
Min EPS beat(4)-142.2%
Max EPS beat(4)1.96%
EPS beat(8)4
Avg EPS beat(8)-77.07%
EPS beat(12)8
Avg EPS beat(12)182.53%
EPS beat(16)9
Avg EPS beat(16)134.8%
Revenue beat(2)1
Avg Revenue beat(2)-3.97%
Min Revenue beat(2)-8.84%
Max Revenue beat(2)0.89%
Revenue beat(4)2
Avg Revenue beat(4)-1.85%
Min Revenue beat(4)-8.84%
Max Revenue beat(4)0.89%
Revenue beat(8)6
Avg Revenue beat(8)-0.34%
Revenue beat(12)10
Avg Revenue beat(12)7.45%
Revenue beat(16)14
Avg Revenue beat(16)8.57%
PT rev (1m)0%
PT rev (3m)-25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.81%
EPS NY rev (1m)0%
EPS NY rev (3m)0.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-15.21%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.61
P/FCF N/A
P/OCF N/A
P/B 0.56
P/tB 0.67
EV/EBITDA N/A
EPS(TTM)-0.8
EYN/A
EPS(NY)-0.78
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.56
OCFYN/A
SpS1.75
BVpS5.05
TBVpS4.23
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.24%
ROE -16.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.41%
FCFM N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
F-Score2
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 36.29%
Cap/Sales 2.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.03
Quick Ratio 6.2
Altman-Z 1.98
F-Score2
WACC9.98%
ROIC/WACCN/A
Cap/Depr(3y)167.19%
Cap/Depr(5y)244.45%
Cap/Sales(3y)7.03%
Cap/Sales(5y)11.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-633.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
EPS Next Y-239.35%
EPS Next 2Y-72.67%
EPS Next 3Y-41.36%
EPS Next 5Y25.37%
Revenue 1Y (TTM)-43.95%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-32.14%
Revenue Next Year-38.37%
Revenue Next 2Y-20.05%
Revenue Next 3Y-11.49%
Revenue Next 5Y-4.62%
EBIT growth 1Y-539.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-91.42%
EBIT Next 3Y-4.37%
EBIT Next 5Y25.91%
FCF growth 1Y-157.36%
FCF growth 3YN/A
FCF growth 5Y117%
OCF growth 1Y-148.56%
OCF growth 3YN/A
OCF growth 5Y22.81%

ORASURE TECHNOLOGIES INC / OSUR FAQ

What is the ChartMill fundamental rating of ORASURE TECHNOLOGIES INC (OSUR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to OSUR.


What is the valuation status of ORASURE TECHNOLOGIES INC (OSUR) stock?

ChartMill assigns a valuation rating of 0 / 10 to ORASURE TECHNOLOGIES INC (OSUR). This can be considered as Overvalued.


Can you provide the profitability details for ORASURE TECHNOLOGIES INC?

ORASURE TECHNOLOGIES INC (OSUR) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for OSUR stock?

The Earnings per Share (EPS) of ORASURE TECHNOLOGIES INC (OSUR) is expected to decline by -239.35% in the next year.